However, in this study, we did not consider more factors, such as tumor size, pathological grade, invasion of peripheral vascular tumors and status of Her-2 and hormone receptor, into our analyses, which may be a deficiency in our survey. This evidence concerns the gene NR4A1 and neoplasm.